방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| HTA(Health Technology Assessment)에서의 비용-효과 분석× | 의료 분야의 균형성과표× | |
|---|---|---|
| 분야 | 의료경영 | 의료경영 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1996 | 1992 |
| 창시자≠ | Diane Meade Drummond, Michael Gold | Robert Kaplan, David Norton |
| 유형≠ | Economic evaluation methodology | Strategic planning and management framework |
| 원전≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 | Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard: Measures that drive performance. Harvard Business Review, 70(1), 71–79. DOI ↗ |
| 별칭 | CEA, Cost-Effectiveness Analysis Healthcare | Healthcare BSC, Balanced Scorecard Healthcare |
| 관련 | 5 | 5 |
| 요약≠ | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. | The Balanced Scorecard is a strategic performance management framework that translates an organization's mission and strategy into a comprehensive set of performance measures across four perspectives: financial, customer, internal processes, and learning and growth. Developed by Kaplan and Norton in 1992 for general business, it has been extensively adapted for healthcare organizations to align hospital operations with strategic objectives. |
| ScholarGate데이터셋 ↗ |
|
|